Executive Summary On Tuesday, March 24, 2015, representatives from the Government Accountability Office (“GAO”), the Department of Health and Human Services Office of the Inspector General (“OIG”) and the Health Resources Services Administration (“HRSA”) testified regarding the drug discount program authorized by Section 340B of the Public Health Services Act (“340B Program”). The testimony took…Read More
340B Program House Subcommittee Testimony: Overview and Insights
Posted on March 30, 2015 in Health Law News
Published by: Hall Render